Circulating innate lymphoid cells and IL-18 as potential immune biomarkers in thymic tumors
Daniela Claudia Maresca(Federico II University Hospital), Giuseppe Ercolano(University of Naples Federico II), Angela Ianaro(University of Naples Federico II), Marianna Tortora(Regione Campania), Mario Giuliano(Regione Campania), Alberto Servetto(University of Naples Federico II), Evelina La Civita(Federico II University Hospital), Benedetta Romano(University of Naples Federico II), Erica Pietroluongo(University of Naples Federico II), Fabio Somma(Federico II University Hospital), Giovannella Palmieri(Regione Campania), Maria Rosaria Saponaro(Federico II University Hospital), Daniela Terracciano(Federico II University Hospital)
Cited by 0
Related Papers
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
|Cancer Treatment Reviews|2018|282
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268